Le rélugolix (Orgovyx®), un nouvel antinéoplasique

Jacques Buxeraud, Sébastien Faure

DOI: 10.1016/j.actpha.2024.10.004

Journal: Actualités Pharmaceutiques

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Download ivySCI

Journal Info

Journals:

ISSN 0515-3700

Quartile

CategoryQuartile
PHARMACOLOGY & PHARMACY4
Built withby Ivy Science